What Slowdown? Chinese Maker Splashing Big On Promotion To Bolster Prices, Growth
This article was originally published in PharmAsia News
Could the economic slowdown in China actually translate into opportunities for domestic drug makers? A recent filing for an initial public offering reveals at least one company is forging full speed ahead by spending big on promotion and planning to add over a thousand sales reps, as it looks to shore up product prices and move deeper into the county-level sector.